timothy sykes logo

Stock News

Walgreens Boots Alliance Stock Plummets: Time to Act?

Ellis HobbsAvatar
Written by Ellis Hobbs Reviewed by Jack Kellogg Fact-checked by Tim Sykes
Walgreens Boots Alliance Stock Plummets: Time to Act? Thumbnail

Rising concerns over labor strikes and supply chain issues are likely to impact Walgreens Boots Alliance Inc.’s performance significantly, with stocks trading down by -6.44 percent on Monday.

Market Woes Cast a Shadow Over Walgreens

  • A lawsuit by the US Department of Justice has taken a heavy toll, accusing Walgreens of improperly dispensing opioids over several years.

Candlestick Chart

Live Update At 14:32:09 EST: On Monday, January 27, 2025 Walgreens Boots Alliance Inc. stock [NASDAQ: WBA] is trending down by -6.44%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

  • Rosen Law Firm steps in, investigating on behalf of shareholders owing to alleged misleading business information released by Walgreens.

  • The stock price has nosedived nearly 14% following the lawsuit, marking a steep decline and sparking concerns among investors.

  • Justice Department’s civil complaint alleges violations of the Controlled Substances Act, triggering a wave of investor apprehensions.

  • Analysts’ views remain mixed despite a price target cut by HSBC, reflecting uncertainty over Walgreens’ immediate future.

Scrutinizing the Earnings: A Deeper Look at Walgreens’ Financial Report

As traders seek to improve their success in the fast-paced world of trading, it is important to focus on developing a disciplined approach. As millionaire penny stock trader and teacher Tim Sykes says, “Be patient, don’t force trades, and let the perfect setups come to you.” By adopting this mindset, traders can make more informed decisions and increase their chances of success without falling into the trap of impulsive trading. The key is to remain vigilant and wait for high-probability opportunities to present themselves, rather than chasing every market movement.

Walgreens Boots Alliance (WBA) has found itself amidst a financial storm, evidenced by its recent earnings report. The reported figures shed light on several challenges, with revenues clocking in at $147.66B. However, profitability appears to be suffering, as reflected by a negative EBIT margin of -9.2 and a profit margin total of -5.87. This paints a worrying picture for Walgreens, which is further compounded by the $605M net loss from continuing operations in its latest quarter.

Meanwhile, the stock’s price-to-sales ratio stands at a mere 0.07, a figure that indicates the company is generating scant revenue for each dollar of stock. Financial strength is equally concerning; the current ratio is alarmingly low at 0.6, signaling potential liquidity issues. Investors are understandably edgy, given these numbers, paired with the looming lawsuit backdrop.

An immediate area of concern is the cash flow, where the operating activities report a negative -$140M. Capital expenditures are also significant at $284M, adding a further financial burden. Insights from these earnings suggest an uphill battle for the company in converting its operations to positive cash flows soon. Burdened by a hefty long-term debt of $27.87B and an increasing leverage ratio, Walgreens appears to be grappling with significant financial constraints that cannot be ignored.

Simply put, Walgreens’ path to recovery seems fraught with challenges. Management will need to re-strategize fundamentally to address these issues and restore investor confidence.

More Breaking News

The Lawsuit Looming Over Walgreens: Unpacking the Information and Its Market Implications

The storm brewing over Walgreens’ head is not just financial. It’s legal. The US Department of Justice has trained its crosshairs on the company, alleging improper opioid dispensing practices dating back to 2012. This is not merely a passing blip; the lawsuit claims numerous unlawful prescriptions were filled, worsening Walgreens’ woes and catalyzing the stock’s steep decline.

A tangible impact of this legal trouble is on share price. It tanked by almost 14%, reflecting market sentiment brimming with anxiety and uncertainty. Investors are wary of the long-drawn legal battles that might ensue, not to mention financial penalties that could dent Walgreens’ already shaky foundation. Amid these developments, the specter of reputational damage looms large, further complicating the company’s market standing.

The implication of this lawsuit extends beyond just legal entanglements; it taps into Walgreens’ operational practices. Allegations of pressuring pharmacists to expedite the dispensing processes, reportedly overlooking prescription legitimacy, have emerged. This puts the firm’s ethical practices under the spotlight, pulling Walgreens’ core operations and compliance track record into question. As the legal proceedings unfold, transparency and accountability become crucial for Walgreens in order to manage the ongoing crisis and rebuild trust.

What Lies Ahead: Strategic Outlook and Market Predictions

A multifaceted approach is vital for Walgreens as it navigates the choppy waters of legal battles, blue-chip expectations, and trader scrutiny. Analyzing key financial metrics reveals a daunting landscape, but understanding the headwinds faced can pave the way for strategic adjustments.

Key ratios indicate bleak profitability margins, necessitating immediate operational overhauls to boost revenue streams and manage costs. Walgreens, despite its commendable market presence, must address substantial liability concerns and exacerbate current challenges—aggressive management interventions are essential.

Moreover, reconciling financial strength with trader expectations will involve bridging the cash flow gap through robust fiscal management and stringent expense control. The looming legal issues make loss prevention and liability mitigation paramount, ensuring that the ongoing litigation doesn’t significantly alter the company’s financial trajectory. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” This mindset could be pivotal for Walgreens in navigating fiscal constraints and optimizing its trading strategies amidst the legal turmoils.

Market sentiment teems with caution, driven by ongoing legal investigations and wavering financial performance. Though analysts hold mixed opinions, the threat of prolonged instability can’t be overlooked. In the coming weeks, decisive action by Walgreens will be imperative in swinging sentiment back in favor and stabilizing stock performance.

Conclusively, Walgreens’ journey through this tumultuous phase hinges on deft navigation of pressing challenges—financial dexterity coupled with legal resolve can mark the beginning of recovery. Meanwhile, the stock market’s eyes will be keenly observing each twist and turn in this unfolding saga.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Our traders will never trade any stock until they see a setup they like. Their strategy is to capture short-term momentum while avoiding undue risk exposure to a stock’s long-term volatility. This method is especially useful when trading penny stocks or other high-risk equities, where rapid gains can be made by understanding stock patterns, manipulation, and media hype. Whether you are an active day trader looking for key indicators on a stock’s next move, or an investor doing due diligence before entering a position, Timothy Sykes News is designed to help you make informed trading decisions.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”